Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 5.44644789 |
2 | keratan sulfate catabolic process (GO:0042340) | 5.32872537 |
3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.18863708 |
4 | protein heterotrimerization (GO:0070208) | 5.15801828 |
5 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.77633745 |
6 | extracellular matrix assembly (GO:0085029) | 4.47926527 |
7 | blood vessel maturation (GO:0001955) | 4.32418564 |
8 | complement activation, alternative pathway (GO:0006957) | 4.11127657 |
9 | regulation of sequestering of triglyceride (GO:0010889) | 4.01931589 |
10 | positive regulation of macrophage cytokine production (GO:0060907) | 3.85143894 |
11 | peripheral nervous system axon ensheathment (GO:0032292) | 3.68985015 |
12 | myelination in peripheral nervous system (GO:0022011) | 3.68985015 |
13 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.66579795 |
14 | glomerular filtration (GO:0003094) | 3.60991019 |
15 | extracellular fibril organization (GO:0043206) | 3.52851997 |
16 | negative regulation of complement activation (GO:0045916) | 3.51312507 |
17 | triglyceride catabolic process (GO:0019433) | 3.43673482 |
18 | lipid particle organization (GO:0034389) | 3.41300118 |
19 | glomerular basement membrane development (GO:0032836) | 3.38187055 |
20 | renal filtration (GO:0097205) | 3.37164348 |
21 | adhesion of symbiont to host cell (GO:0044650) | 3.36641746 |
22 | virion attachment to host cell (GO:0019062) | 3.36641746 |
23 | collagen fibril organization (GO:0030199) | 3.33568656 |
24 | positive regulation of fatty acid oxidation (GO:0046321) | 3.28866834 |
25 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.23684269 |
26 | negative regulation of protein autophosphorylation (GO:0031953) | 3.21606761 |
27 | brown fat cell differentiation (GO:0050873) | 3.20524883 |
28 | membrane raft organization (GO:0031579) | 3.17698426 |
29 | creatine metabolic process (GO:0006600) | 3.15882733 |
30 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.13728530 |
31 | cellular response to nitric oxide (GO:0071732) | 3.13325747 |
32 | * barbed-end actin filament capping (GO:0051016) | 3.11858405 |
33 | white fat cell differentiation (GO:0050872) | 3.10479805 |
34 | positive regulation of cholesterol efflux (GO:0010875) | 3.06411348 |
35 | positive regulation of p38MAPK cascade (GO:1900745) | 3.05256608 |
36 | regulation of endothelial cell differentiation (GO:0045601) | 3.03157123 |
37 | adhesion of symbiont to host (GO:0044406) | 3.01820789 |
38 | ovulation from ovarian follicle (GO:0001542) | 3.01350552 |
39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.01327112 |
40 | regulation of macrophage cytokine production (GO:0010935) | 2.99504092 |
41 | acylglycerol catabolic process (GO:0046464) | 2.98519486 |
42 | neutral lipid catabolic process (GO:0046461) | 2.98519486 |
43 | fibril organization (GO:0097435) | 2.98289892 |
44 | transcytosis (GO:0045056) | 2.98149074 |
45 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.97090942 |
46 | growth hormone receptor signaling pathway (GO:0060396) | 2.95707369 |
47 | import into cell (GO:0098657) | 2.95606669 |
48 | apoptotic cell clearance (GO:0043277) | 2.95141431 |
49 | basement membrane organization (GO:0071711) | 2.93041851 |
50 | endothelial cell morphogenesis (GO:0001886) | 2.92943149 |
51 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.90355387 |
52 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.88333326 |
53 | collagen metabolic process (GO:0032963) | 2.88106666 |
54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87978668 |
55 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87978668 |
56 | dermatan sulfate biosynthetic process (GO:0030208) | 2.87021169 |
57 | positive regulation of receptor recycling (GO:0001921) | 2.86875781 |
58 | fatty acid transmembrane transport (GO:1902001) | 2.84834238 |
59 | regulation of complement activation (GO:0030449) | 2.84135302 |
60 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83651228 |
61 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.81893348 |
62 | regulation of cholesterol storage (GO:0010885) | 2.81738253 |
63 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.80641594 |
64 | regulation of p38MAPK cascade (GO:1900744) | 2.80447083 |
65 | opsonization (GO:0008228) | 2.79952491 |
66 | multicellular organismal metabolic process (GO:0044236) | 2.79866962 |
67 | negative regulation of stress fiber assembly (GO:0051497) | 2.79825542 |
68 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.79700331 |
69 | collagen catabolic process (GO:0030574) | 2.79686611 |
70 | cellular response to epinephrine stimulus (GO:0071872) | 2.78306252 |
71 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.77992558 |
72 | negative regulation of protein activation cascade (GO:2000258) | 2.75949113 |
73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73077083 |
74 | valine metabolic process (GO:0006573) | 2.72450105 |
75 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.71442778 |
76 | biotin metabolic process (GO:0006768) | 2.70996713 |
77 | triglyceride biosynthetic process (GO:0019432) | 2.69322889 |
78 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.68908689 |
79 | multicellular organismal catabolic process (GO:0044243) | 2.67609895 |
80 | bone trabecula formation (GO:0060346) | 2.66622159 |
81 | pinocytosis (GO:0006907) | 2.65020169 |
82 | stress fiber assembly (GO:0043149) | 2.64882258 |
83 | negative regulation of granulocyte differentiation (GO:0030853) | 2.64656780 |
84 | positive regulation of glucose import (GO:0046326) | 2.64237311 |
85 | dermatan sulfate metabolic process (GO:0030205) | 2.61655364 |
86 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.60836093 |
87 | cGMP-mediated signaling (GO:0019934) | 2.60598061 |
88 | positive regulation of sterol transport (GO:0032373) | 2.60588458 |
89 | positive regulation of cholesterol transport (GO:0032376) | 2.60588458 |
90 | cellular response to growth hormone stimulus (GO:0071378) | 2.59522260 |
91 | neutral lipid biosynthetic process (GO:0046460) | 2.58916164 |
92 | acylglycerol biosynthetic process (GO:0046463) | 2.58916164 |
93 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.58755815 |
94 | plasma lipoprotein particle clearance (GO:0034381) | 2.58467166 |
95 | protein localization to endosome (GO:0036010) | 2.57847273 |
96 | thioester biosynthetic process (GO:0035384) | 2.56973870 |
97 | acyl-CoA biosynthetic process (GO:0071616) | 2.56973870 |
98 | regulation of macrophage chemotaxis (GO:0010758) | 2.56606967 |
99 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.56570201 |
100 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.55638755 |
101 | response to nitric oxide (GO:0071731) | 2.55496469 |
102 | NADH metabolic process (GO:0006734) | 2.54923503 |
103 | regulation of vasculogenesis (GO:2001212) | 2.54836329 |
104 | regulation of mononuclear cell migration (GO:0071675) | 2.54393560 |
105 | cell migration involved in heart development (GO:0060973) | 2.54279711 |
106 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.53291123 |
107 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53154899 |
108 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.52793873 |
109 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.52632639 |
110 | regulation of fatty acid oxidation (GO:0046320) | 2.52155314 |
111 | sulfur compound catabolic process (GO:0044273) | 2.51891878 |
112 | cellular response to reactive nitrogen species (GO:1902170) | 2.51394188 |
113 | mannose metabolic process (GO:0006013) | 2.50825617 |
114 | epithelial cell-cell adhesion (GO:0090136) | 2.50489618 |
115 | regulation of protein activation cascade (GO:2000257) | 2.49410304 |
116 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.48509265 |
117 | lymph vessel development (GO:0001945) | 2.48337972 |
118 | response to dietary excess (GO:0002021) | 2.48219861 |
119 | extracellular matrix disassembly (GO:0022617) | 2.47222417 |
120 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.47174351 |
121 | lymphangiogenesis (GO:0001946) | 2.46381913 |
122 | axon ensheathment (GO:0008366) | 2.44903396 |
123 | ensheathment of neurons (GO:0007272) | 2.44903396 |
124 | lipid storage (GO:0019915) | 2.44793572 |
125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.44688589 |
126 | regulation of apoptotic cell clearance (GO:2000425) | 2.44055857 |
127 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43641951 |
128 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.43333074 |
129 | endothelium development (GO:0003158) | 2.42776352 |
130 | regulation of lipoprotein metabolic process (GO:0050746) | 2.42684435 |
131 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.42540184 |
132 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.41991852 |
133 | polyol transport (GO:0015791) | 2.36116901 |
134 | angiogenesis involved in wound healing (GO:0060055) | 2.35980918 |
135 | ethanol oxidation (GO:0006069) | 2.35934355 |
136 | positive regulation of lipid storage (GO:0010884) | 2.32379837 |
137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.32064941 |
138 | response to thyroid hormone (GO:0097066) | 2.31632343 |
139 | response to epinephrine (GO:0071871) | 2.29512577 |
140 | glycosphingolipid catabolic process (GO:0046479) | 2.28490707 |
141 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.26831743 |
142 | regulation of extracellular matrix disassembly (GO:0010715) | 2.24735208 |
143 | cortical actin cytoskeleton organization (GO:0030866) | 2.22286807 |
144 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.22209574 |
145 | cell volume homeostasis (GO:0006884) | 2.19045191 |
146 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.16873195 |
147 | glycerolipid catabolic process (GO:0046503) | 2.15893268 |
148 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.14493085 |
149 | negative regulation of platelet activation (GO:0010544) | 2.13631703 |
150 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.12244142 |
151 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.12162659 |
152 | surfactant homeostasis (GO:0043129) | 2.11657755 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.10099057 |
154 | peptide catabolic process (GO:0043171) | 2.07150982 |
155 | cortical cytoskeleton organization (GO:0030865) | 2.06514574 |
156 | oligosaccharide catabolic process (GO:0009313) | 2.04529107 |
157 | ethanol metabolic process (GO:0006067) | 2.03146407 |
158 | cell-substrate junction assembly (GO:0007044) | 2.02601038 |
159 | glycolipid catabolic process (GO:0019377) | 2.02265563 |
160 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.02079147 |
161 | glial cell migration (GO:0008347) | 2.01659474 |
162 | regulation of cholesterol efflux (GO:0010874) | 2.01655998 |
163 | low-density lipoprotein particle remodeling (GO:0034374) | 2.00515138 |
164 | endodermal cell differentiation (GO:0035987) | 1.98851668 |
165 | negative regulation of adherens junction organization (GO:1903392) | 1.98766944 |
166 | negative regulation of focal adhesion assembly (GO:0051895) | 1.98766944 |
167 | negative regulation of cell junction assembly (GO:1901889) | 1.98766944 |
168 | negative regulation of lipid storage (GO:0010888) | 1.98295381 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.29016497 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.38212023 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.62236564 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.55568794 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07111431 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.98503501 |
7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.70170773 |
8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.64919671 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50488277 |
10 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.33498427 |
11 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.31546730 |
12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.03659991 |
13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.01820094 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89523246 |
15 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87711421 |
16 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.87442802 |
17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.83815660 |
18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82781937 |
19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62801011 |
20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61961220 |
21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.59138584 |
22 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56858281 |
23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51530496 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48043742 |
25 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.47161150 |
26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45435752 |
27 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45339373 |
28 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45339373 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44552301 |
30 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44459374 |
31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.42000226 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40673860 |
33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40648381 |
34 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37806356 |
35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37398371 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36541588 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36541588 |
38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36460377 |
39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36087870 |
40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36087870 |
41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35661222 |
42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33140943 |
43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32329735 |
44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32201217 |
45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30694423 |
46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29609391 |
47 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.28779858 |
48 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27577119 |
49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26809115 |
50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25016926 |
51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18328347 |
52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18032442 |
53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17959374 |
54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17769046 |
55 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16112229 |
56 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15472045 |
57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15063568 |
58 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14354408 |
59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14109903 |
60 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.14085089 |
61 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13602476 |
62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.13432107 |
63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09821072 |
64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09629511 |
65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09145929 |
66 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.08086456 |
67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07950902 |
68 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07393257 |
69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07372307 |
70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06929204 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06813896 |
72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06512899 |
73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06454061 |
74 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.05555903 |
75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05300011 |
76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05011915 |
77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03070661 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02925905 |
79 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01709238 |
80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01413758 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00545579 |
82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00297887 |
83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99837083 |
84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99510403 |
85 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97863114 |
86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97789969 |
87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97520934 |
88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96793308 |
89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96564289 |
90 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96423026 |
91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96333044 |
92 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95018712 |
93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94811710 |
94 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94298195 |
95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94285380 |
96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93928149 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93672290 |
98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93522890 |
99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93272571 |
100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93239010 |
101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92963243 |
102 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92803671 |
103 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92676797 |
104 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92465380 |
105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92434066 |
106 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90925609 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90294402 |
108 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90288273 |
109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90275364 |
110 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89521676 |
111 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89169984 |
112 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88650014 |
113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88419362 |
114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88184541 |
115 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88105065 |
116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87204412 |
117 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.86365302 |
118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86329190 |
119 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84731877 |
120 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84573575 |
121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83966733 |
122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83512069 |
123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83364218 |
124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82965966 |
125 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.82582193 |
126 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81081697 |
127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80662871 |
128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80544704 |
129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.80309586 |
130 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80276865 |
131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79854413 |
132 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79383454 |
133 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79383454 |
134 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.78002032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 8.13429595 |
2 | MP0005275_abnormal_skin_tensile | 6.21639559 |
3 | MP0005503_abnormal_tendon_morphology | 4.91342356 |
4 | MP0005670_abnormal_white_adipose | 3.37810348 |
5 | MP0004272_abnormal_basement_membrane | 3.08181720 |
6 | MP0001958_emphysema | 3.06701306 |
7 | MP0000751_myopathy | 2.51527433 |
8 | MP0005666_abnormal_adipose_tissue | 2.51350849 |
9 | MP0009840_abnormal_foam_cell | 2.46193920 |
10 | MP0004130_abnormal_muscle_cell | 2.44911332 |
11 | MP0004185_abnormal_adipocyte_glucose | 2.44025657 |
12 | MP0003950_abnormal_plasma_membrane | 2.39034522 |
13 | MP0000013_abnormal_adipose_tissue | 2.27578658 |
14 | MP0005375_adipose_tissue_phenotype | 2.17403801 |
15 | MP0002837_dystrophic_cardiac_calcinosis | 2.15920044 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.08856485 |
17 | MP0003724_increased_susceptibility_to | 2.05779317 |
18 | MP0002108_abnormal_muscle_morphology | 1.97737140 |
19 | MP0002060_abnormal_skin_morphology | 1.92750418 |
20 | MP0010368_abnormal_lymphatic_system | 1.89811597 |
21 | MP0000003_abnormal_adipose_tissue | 1.82083580 |
22 | MP0003566_abnormal_cell_adhesion | 1.78298353 |
23 | MP0006054_spinal_hemorrhage | 1.73454317 |
24 | MP0001879_abnormal_lymphatic_vessel | 1.63799089 |
25 | MP0003279_aneurysm | 1.63516616 |
26 | MP0003303_peritoneal_inflammation | 1.59981823 |
27 | MP0001661_extended_life_span | 1.59379244 |
28 | MP0005257_abnormal_intraocular_pressure | 1.58397207 |
29 | MP0004510_myositis | 1.52494765 |
30 | MP0000604_amyloidosis | 1.50715026 |
31 | MP0000343_altered_response_to | 1.48975220 |
32 | MP0000749_muscle_degeneration | 1.47762810 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.44634560 |
34 | MP0003011_delayed_dark_adaptation | 1.39665971 |
35 | MP0003690_abnormal_glial_cell | 1.36920448 |
36 | MP0006138_congestive_heart_failure | 1.34616480 |
37 | MP0006082_CNS_inflammation | 1.34203401 |
38 | MP0003329_amyloid_beta_deposits | 1.33905322 |
39 | MP0000750_abnormal_muscle_regeneration | 1.33396883 |
40 | MP0003828_pulmonary_edema | 1.33198309 |
41 | MP0003172_abnormal_lysosome_physiology | 1.32108886 |
42 | MP0002877_abnormal_melanocyte_morpholog | 1.30959402 |
43 | MP0003436_decreased_susceptibility_to | 1.30699695 |
44 | MP0000920_abnormal_myelination | 1.29295929 |
45 | * MP0005165_increased_susceptibility_to | 1.28345095 |
46 | MP0005409_darkened_coat_color | 1.28218125 |
47 | * MP0003075_altered_response_to | 1.28045644 |
48 | MP0002971_abnormal_brown_adipose | 1.26455938 |
49 | MP0004036_abnormal_muscle_relaxation | 1.21916621 |
50 | * MP0005508_abnormal_skeleton_morphology | 1.21341361 |
51 | MP0003300_gastrointestinal_ulcer | 1.20486031 |
52 | MP0003453_abnormal_keratinocyte_physiol | 1.18641222 |
53 | * MP0002295_abnormal_pulmonary_circulatio | 1.15773738 |
54 | MP0002933_joint_inflammation | 1.13068517 |
55 | MP0002896_abnormal_bone_mineralization | 1.10029495 |
56 | MP0004087_abnormal_muscle_fiber | 1.09773683 |
57 | MP0004084_abnormal_cardiac_muscle | 1.09415788 |
58 | MP0005330_cardiomyopathy | 1.08992006 |
59 | MP0005388_respiratory_system_phenotype | 1.08191358 |
60 | MP0002133_abnormal_respiratory_system | 1.08191358 |
61 | MP0002166_altered_tumor_susceptibility | 1.08027527 |
62 | MP0009115_abnormal_fat_cell | 1.07737099 |
63 | MP0000858_altered_metastatic_potential | 1.07642554 |
64 | MP0002796_impaired_skin_barrier | 1.06730082 |
65 | MP0005334_abnormal_fat_pad | 1.06647568 |
66 | * MP0002419_abnormal_innate_immunity | 1.05662599 |
67 | MP0005595_abnormal_vascular_smooth | 1.05268290 |
68 | MP0005385_cardiovascular_system_phenoty | 1.04678575 |
69 | MP0001544_abnormal_cardiovascular_syste | 1.04678575 |
70 | MP0003045_fibrosis | 1.04652890 |
71 | MP0005164_abnormal_response_to | 1.04431673 |
72 | MP0005620_abnormal_muscle_contractility | 1.01909933 |
73 | MP0009278_abnormal_bone_marrow | 1.01236743 |
74 | MP0004883_abnormal_blood_vessel | 1.01158752 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 1.00893281 |
76 | MP0000759_abnormal_skeletal_muscle | 1.00393275 |
77 | MP0005369_muscle_phenotype | 0.98292007 |
78 | MP0001243_abnormal_dermal_layer | 0.96935234 |
79 | MP0002876_abnormal_thyroid_physiology | 0.96851747 |
80 | MP0005623_abnormal_meninges_morphology | 0.96051680 |
81 | MP0000747_muscle_weakness | 0.95903523 |
82 | MP0010329_abnormal_lipoprotein_level | 0.95054337 |
83 | MP0005166_decreased_susceptibility_to | 0.94606937 |
84 | MP0004858_abnormal_nervous_system | 0.93665521 |
85 | MP0008260_abnormal_autophagy | 0.93626365 |
86 | MP0002118_abnormal_lipid_homeostasis | 0.91852148 |
87 | MP0008004_abnormal_stomach_pH | 0.91088151 |
88 | MP0002972_abnormal_cardiac_muscle | 0.91024640 |
89 | MP0008775_abnormal_heart_ventricle | 0.90324909 |
90 | MP0000767_abnormal_smooth_muscle | 0.89369666 |
91 | MP0005451_abnormal_body_composition | 0.87595381 |
92 | MP0005397_hematopoietic_system_phenotyp | 0.87110405 |
93 | MP0001545_abnormal_hematopoietic_system | 0.87110405 |
94 | MP0002148_abnormal_hypersensitivity_rea | 0.84368440 |
95 | MP0000733_abnormal_muscle_development | 0.82409894 |
96 | * MP0005390_skeleton_phenotype | 0.80554681 |
97 | MP0004147_increased_porphyrin_level | 0.79824223 |
98 | MP0003959_abnormal_lean_body | 0.78877137 |
99 | MP0005058_abnormal_lysosome_morphology | 0.77314503 |
100 | MP0005025_abnormal_response_to | 0.77056271 |
101 | MP0009785_altered_susceptibility_to | 0.76304188 |
102 | MP0005167_abnormal_blood-brain_barrier | 0.76268912 |
103 | MP0003634_abnormal_glial_cell | 0.75779525 |
104 | * MP0000249_abnormal_blood_vessel | 0.75675003 |
105 | MP0003091_abnormal_cell_migration | 0.73978811 |
106 | * MP0001533_abnormal_skeleton_physiology | 0.73855112 |
107 | MP0002106_abnormal_muscle_physiology | 0.73434192 |
108 | MP0001756_abnormal_urination | 0.71715377 |
109 | MP0002970_abnormal_white_adipose | 0.70956827 |
110 | MP0003448_altered_tumor_morphology | 0.70822046 |
111 | MP0002138_abnormal_hepatobiliary_system | 0.68366162 |
112 | * MP0005023_abnormal_wound_healing | 0.68151784 |
113 | MP0004484_altered_response_of | 0.65643311 |
114 | MP0002006_tumorigenesis | 0.65056998 |
115 | MP0010771_integument_phenotype | 0.65039909 |
116 | MP0002128_abnormal_blood_circulation | 0.64507911 |
117 | MP0002168_other_aberrant_phenotype | 0.64254486 |
118 | MP0001614_abnormal_blood_vessel | 0.63683311 |
119 | MP0010630_abnormal_cardiac_muscle | 0.62397672 |
120 | MP0009384_cardiac_valve_regurgitation | 0.61690468 |
121 | MP0001177_atelectasis | 0.61147044 |
122 | MP0001175_abnormal_lung_morphology | 0.59298640 |
123 | MP0000230_abnormal_systemic_arterial | 0.58664655 |
124 | MP0001851_eye_inflammation | 0.57749197 |
125 | MP0004215_abnormal_myocardial_fiber | 0.56584391 |
126 | MP0001542_abnormal_bone_strength | 0.56058724 |
127 | MP0002254_reproductive_system_inflammat | 0.54078432 |
128 | MP0001727_abnormal_embryo_implantation | 0.53919974 |
129 | * MP0002998_abnormal_bone_remodeling | 0.51593227 |
130 | * MP0000163_abnormal_cartilage_morphology | 0.50275733 |
131 | MP0002090_abnormal_vision | 0.50199637 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Broad metatarsal (HP:0001783) | 5.90979600 |
2 | Protrusio acetabuli (HP:0003179) | 5.38497742 |
3 | Premature rupture of membranes (HP:0001788) | 5.28837787 |
4 | Ankle contracture (HP:0006466) | 5.23982936 |
5 | Muscle fiber splitting (HP:0003555) | 4.68458588 |
6 | Increased connective tissue (HP:0009025) | 4.55588755 |
7 | Acanthosis nigricans (HP:0000956) | 4.11609950 |
8 | Type 1 muscle fiber predominance (HP:0003803) | 4.03886131 |
9 | Complement deficiency (HP:0004431) | 4.03238451 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89243800 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89243800 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89243800 |
13 | Aortic dissection (HP:0002647) | 3.88731632 |
14 | Spinal rigidity (HP:0003306) | 3.73997911 |
15 | Wrist flexion contracture (HP:0001239) | 3.71334607 |
16 | Increased variability in muscle fiber diameter (HP:0003557) | 3.57706151 |
17 | Follicular hyperkeratosis (HP:0007502) | 3.50063416 |
18 | Cerebral aneurysm (HP:0004944) | 3.46124037 |
19 | Cervical subluxation (HP:0003308) | 3.44670364 |
20 | Dysostosis multiplex (HP:0000943) | 3.35847192 |
21 | Distal lower limb muscle weakness (HP:0009053) | 3.35672890 |
22 | Asymmetric septal hypertrophy (HP:0001670) | 3.33978814 |
23 | Right ventricular cardiomyopathy (HP:0011663) | 3.27212506 |
24 | Soft skin (HP:0000977) | 3.25939766 |
25 | Difficulty running (HP:0009046) | 3.19549366 |
26 | Shallow orbits (HP:0000586) | 3.17044274 |
27 | Myocardial infarction (HP:0001658) | 3.14152013 |
28 | Hyporeflexia of lower limbs (HP:0002600) | 3.14007870 |
29 | Round ear (HP:0100830) | 3.12658028 |
30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.10451553 |
31 | Aortic aneurysm (HP:0004942) | 3.10255166 |
32 | Hematochezia (HP:0002573) | 3.07822983 |
33 | Systemic lupus erythematosus (HP:0002725) | 3.04628606 |
34 | Abnormality of complement system (HP:0005339) | 3.03733209 |
35 | Glomerulonephritis (HP:0000099) | 2.95904296 |
36 | Oligomenorrhea (HP:0000876) | 2.93314948 |
37 | Vacuolated lymphocytes (HP:0001922) | 2.86467801 |
38 | Spontaneous hematomas (HP:0007420) | 2.84128200 |
39 | Slender build (HP:0001533) | 2.81491999 |
40 | Polycythemia (HP:0001901) | 2.74005768 |
41 | Pulmonary artery stenosis (HP:0004415) | 2.70352447 |
42 | Bladder diverticulum (HP:0000015) | 2.68274055 |
43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67914879 |
44 | Mucopolysacchariduria (HP:0008155) | 2.67914879 |
45 | Ileus (HP:0002595) | 2.67590068 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66034127 |
47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66034127 |
48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66034127 |
49 | Vertebral compression fractures (HP:0002953) | 2.54918066 |
50 | Osteolytic defects of the hand bones (HP:0009699) | 2.53544805 |
51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53544805 |
52 | Cerebral hemorrhage (HP:0001342) | 2.48620615 |
53 | Nuclear cataract (HP:0100018) | 2.46680158 |
54 | Distal lower limb amyotrophy (HP:0008944) | 2.42039484 |
55 | Atrophic scars (HP:0001075) | 2.40638363 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.37571056 |
57 | Hypertriglyceridemia (HP:0002155) | 2.37373359 |
58 | Increased cerebral lipofuscin (HP:0011813) | 2.36410260 |
59 | Mitral valve prolapse (HP:0001634) | 2.35497039 |
60 | Dilatation of the ascending aorta (HP:0005111) | 2.35235967 |
61 | Xanthomatosis (HP:0000991) | 2.34267755 |
62 | Lipoatrophy (HP:0100578) | 2.32248073 |
63 | Bronchomalacia (HP:0002780) | 2.32010875 |
64 | Neonatal short-limb short stature (HP:0008921) | 2.31863440 |
65 | Neurofibrillary tangles (HP:0002185) | 2.30532275 |
66 | Wormian bones (HP:0002645) | 2.30466556 |
67 | Abnormality of the nasal mucosa (HP:0000433) | 2.29825182 |
68 | Growth hormone excess (HP:0000845) | 2.28513212 |
69 | Hypoplasia of the iris (HP:0007676) | 2.25473275 |
70 | Eczematoid dermatitis (HP:0000976) | 2.25255907 |
71 | Joint stiffness (HP:0001387) | 2.23559086 |
72 | Ventricular tachycardia (HP:0004756) | 2.21507525 |
73 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.20053650 |
74 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.18356149 |
75 | Hyperextensible skin (HP:0000974) | 2.11270995 |
76 | Vascular tortuosity (HP:0004948) | 2.09812547 |
77 | Purpura (HP:0000979) | 2.09719657 |
78 | Loss of speech (HP:0002371) | 2.09509799 |
79 | Disproportionate tall stature (HP:0001519) | 2.09174031 |
80 | Venous abnormality (HP:0002624) | 2.06926436 |
81 | Peritonitis (HP:0002586) | 2.06829089 |
82 | Stridor (HP:0010307) | 2.06650979 |
83 | Rectal prolapse (HP:0002035) | 2.06123420 |
84 | Nephritis (HP:0000123) | 2.04561950 |
85 | Abnormality of macrophages (HP:0004311) | 2.04367269 |
86 | Skin nodule (HP:0200036) | 2.02672506 |
87 | Premature skin wrinkling (HP:0100678) | 2.02499151 |
88 | Bundle branch block (HP:0011710) | 2.02394371 |
89 | Esophageal varix (HP:0002040) | 2.01715884 |
90 | Scapular winging (HP:0003691) | 2.00959520 |
91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00004137 |
92 | Exercise-induced myalgia (HP:0003738) | 1.99223458 |
93 | Aneurysm (HP:0002617) | 1.99109203 |
94 | Myotonia (HP:0002486) | 1.98185552 |
95 | Fragile skin (HP:0001030) | 1.97804651 |
96 | Camptodactyly of toe (HP:0001836) | 1.96679077 |
97 | Blue sclerae (HP:0000592) | 1.96436676 |
98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.95490133 |
99 | Striae distensae (HP:0001065) | 1.94514684 |
100 | Venous insufficiency (HP:0005293) | 1.92945555 |
101 | Calf muscle hypertrophy (HP:0008981) | 1.92557931 |
102 | Bone cyst (HP:0012062) | 1.90626139 |
103 | Flat cornea (HP:0007720) | 1.89928882 |
104 | Mitral stenosis (HP:0001718) | 1.89204271 |
105 | Tarsal synostosis (HP:0008368) | 1.89097184 |
106 | Foot dorsiflexor weakness (HP:0009027) | 1.89022189 |
107 | Sudden death (HP:0001699) | 1.88999373 |
108 | Malnutrition (HP:0004395) | 1.88429118 |
109 | Bell-shaped thorax (HP:0001591) | 1.88412437 |
110 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88398763 |
111 | Abnormality of the periventricular white matter (HP:0002518) | 1.87730067 |
112 | Arterial tortuosity (HP:0005116) | 1.86536105 |
113 | Axonal loss (HP:0003447) | 1.86449792 |
114 | Ovoid vertebral bodies (HP:0003300) | 1.86040107 |
115 | Neck muscle weakness (HP:0000467) | 1.84735286 |
116 | Gastrointestinal dysmotility (HP:0002579) | 1.83725910 |
117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83575403 |
118 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.82553206 |
119 | Joint laxity (HP:0001388) | 1.82372746 |
120 | Cerebral inclusion bodies (HP:0100314) | 1.81296697 |
121 | Hemorrhage of the eye (HP:0011885) | 1.80591902 |
122 | Muscle stiffness (HP:0003552) | 1.80486753 |
123 | Abnormal atrioventricular conduction (HP:0005150) | 1.78257919 |
124 | Generalized amyotrophy (HP:0003700) | 1.78171386 |
125 | J-shaped sella turcica (HP:0002680) | 1.78022239 |
126 | Thin bony cortex (HP:0002753) | 1.77642606 |
127 | EMG: myopathic abnormalities (HP:0003458) | 1.76758483 |
128 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75809160 |
129 | Mutism (HP:0002300) | 1.75110307 |
130 | Thick nail (HP:0001805) | 1.74386301 |
131 | Hip contracture (HP:0003273) | 1.74356521 |
132 | Interstitial pulmonary disease (HP:0006530) | 1.74333614 |
133 | Joint hemorrhage (HP:0005261) | 1.74064383 |
134 | Abnormality of the foot musculature (HP:0001436) | 1.72894641 |
135 | Duplicated collecting system (HP:0000081) | 1.71834822 |
136 | Spondylolisthesis (HP:0003302) | 1.71815112 |
137 | Ulnar bowing (HP:0003031) | 1.71540381 |
138 | Visceral angiomatosis (HP:0100761) | 1.71330487 |
139 | Abnormality of the calf musculature (HP:0001430) | 1.70652915 |
140 | Broad ribs (HP:0000885) | 1.68626550 |
141 | Proximal amyotrophy (HP:0007126) | 1.68202320 |
142 | Hypoalphalipoproteinemia (HP:0003233) | 1.67554079 |
143 | Gingivitis (HP:0000230) | 1.67386406 |
144 | Gingival overgrowth (HP:0000212) | 1.67249081 |
145 | * Amyloidosis (HP:0011034) | 1.66838463 |
146 | Stroke (HP:0001297) | 1.65218772 |
147 | Ventricular arrhythmia (HP:0004308) | 1.64337122 |
148 | Atrial fibrillation (HP:0005110) | 1.63789246 |
149 | Short nail (HP:0001799) | 1.63775095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 3.72591418 |
2 | INSRR | 3.52121897 |
3 | TRIB3 | 3.49395008 |
4 | EPHB1 | 3.22606916 |
5 | TGFBR2 | 3.20324672 |
6 | TTN | 3.17754748 |
7 | CAMK1D | 2.95309094 |
8 | CAMK1G | 2.40549963 |
9 | MET | 2.31610967 |
10 | DDR2 | 2.22658015 |
11 | MYLK | 2.20941478 |
12 | ERN1 | 2.20328257 |
13 | PDGFRA | 2.19233960 |
14 | TESK1 | 2.13136779 |
15 | RIPK1 | 2.04607932 |
16 | SIK1 | 2.02303712 |
17 | TRPM7 | 2.01485972 |
18 | STK39 | 1.92754294 |
19 | MST1R | 1.90456003 |
20 | LMTK2 | 1.87136108 |
21 | EPHB2 | 1.72981591 |
22 | FGFR2 | 1.69219434 |
23 | EPHA3 | 1.68067154 |
24 | FER | 1.65689002 |
25 | BLK | 1.55184594 |
26 | CDC42BPA | 1.53693437 |
27 | BCKDK | 1.48576075 |
28 | MAPKAPK3 | 1.46209899 |
29 | FGFR4 | 1.41815618 |
30 | ABL2 | 1.32925616 |
31 | MAPKAPK5 | 1.29705441 |
32 | DMPK | 1.24675172 |
33 | PHKG2 | 1.22693473 |
34 | PHKG1 | 1.22693473 |
35 | TBK1 | 1.18515405 |
36 | BCR | 1.16680933 |
37 | PRKD1 | 1.15152684 |
38 | PRPF4B | 1.14735092 |
39 | NTRK1 | 1.11769558 |
40 | PRKCH | 1.09836160 |
41 | ZAP70 | 1.07731307 |
42 | PRKD2 | 1.06442115 |
43 | PKN1 | 1.05256781 |
44 | PDGFRB | 1.03654083 |
45 | PAK2 | 1.01207500 |
46 | PIK3CA | 0.99617876 |
47 | EEF2K | 0.97855915 |
48 | PRKD3 | 0.97707548 |
49 | MAP3K13 | 0.96534589 |
50 | PTK2B | 0.94473103 |
51 | JAK1 | 0.93646697 |
52 | ILK | 0.93463046 |
53 | ARAF | 0.93438226 |
54 | GRK7 | 0.91841753 |
55 | MAP3K11 | 0.91724594 |
56 | MAPK7 | 0.91546655 |
57 | ROCK2 | 0.91016041 |
58 | RIPK4 | 0.90913676 |
59 | PDK2 | 0.90019645 |
60 | OBSCN | 0.87015812 |
61 | PDK3 | 0.86990657 |
62 | PDK4 | 0.86990657 |
63 | EPHA2 | 0.86655089 |
64 | PTK6 | 0.85088374 |
65 | NME2 | 0.84987090 |
66 | MAP3K1 | 0.84181459 |
67 | OXSR1 | 0.83548885 |
68 | MAP3K3 | 0.83508105 |
69 | PRKAA2 | 0.83405498 |
70 | RPS6KA2 | 0.82835363 |
71 | IRAK3 | 0.80894553 |
72 | LATS1 | 0.80453290 |
73 | PINK1 | 0.79487067 |
74 | FGFR3 | 0.78860785 |
75 | WNK1 | 0.77995682 |
76 | FES | 0.77731340 |
77 | MAPK4 | 0.77656055 |
78 | LRRK2 | 0.77174152 |
79 | GSK3A | 0.75213260 |
80 | MAP3K14 | 0.69970237 |
81 | PRKG2 | 0.67194035 |
82 | PIM2 | 0.64190787 |
83 | ROCK1 | 0.63535393 |
84 | CAMK1 | 0.61775086 |
85 | KDR | 0.61455216 |
86 | PDPK1 | 0.61131047 |
87 | CAMK2G | 0.60416731 |
88 | BMX | 0.60098256 |
89 | PIK3CG | 0.59451119 |
90 | CAMKK2 | 0.59447330 |
91 | MAP2K1 | 0.58784844 |
92 | * CSK | 0.56656443 |
93 | PAK3 | 0.55763637 |
94 | RET | 0.55667704 |
95 | MUSK | 0.55355754 |
96 | MAPK15 | 0.54873759 |
97 | SGK3 | 0.54697922 |
98 | MAP2K3 | 0.54656049 |
99 | MAP2K2 | 0.54404505 |
100 | MOS | 0.53407586 |
101 | CSF1R | 0.53082802 |
102 | LIMK1 | 0.52916409 |
103 | JAK2 | 0.52608762 |
104 | WNK4 | 0.51465535 |
105 | RPS6KL1 | 0.51212200 |
106 | RPS6KC1 | 0.51212200 |
107 | KSR2 | 0.50645811 |
108 | DAPK3 | 0.49500210 |
109 | PDK1 | 0.48813541 |
110 | PTK2 | 0.48706094 |
111 | TAOK2 | 0.48003028 |
112 | MAP3K6 | 0.47182527 |
113 | PRKCE | 0.47155142 |
114 | GRK1 | 0.46706329 |
115 | HIPK2 | 0.46434794 |
116 | MARK2 | 0.45745386 |
117 | INSR | 0.45160339 |
118 | MAP3K7 | 0.44923294 |
119 | ICK | 0.44415212 |
120 | LATS2 | 0.42439352 |
121 | MAPK12 | 0.41066213 |
122 | IGF1R | 0.39574166 |
123 | TYK2 | 0.39373819 |
124 | CAMK2D | 0.37856322 |
125 | MAP3K2 | 0.36277093 |
126 | DAPK2 | 0.35781543 |
127 | * SRC | 0.34845612 |
128 | TGFBR1 | 0.34669590 |
129 | FRK | 0.34594332 |
130 | PAK6 | 0.33246559 |
131 | FGR | 0.32855178 |
132 | MAPKAPK2 | 0.32739429 |
133 | STK10 | 0.31630978 |
134 | MTOR | 0.31484137 |
135 | KIT | 0.31459959 |
136 | JAK3 | 0.31337854 |
137 | ABL1 | 0.30373293 |
138 | NEK9 | 0.29181718 |
139 | PAK4 | 0.28090659 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.45538003 |
2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.13063371 |
3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.68737743 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.40860584 |
5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.37267525 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18178910 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.16480845 |
8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02395748 |
9 | Focal adhesion_Homo sapiens_hsa04510 | 1.98398117 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78769467 |
11 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.65977586 |
12 | Malaria_Homo sapiens_hsa05144 | 1.64176837 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63283039 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60994773 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59359650 |
16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56018557 |
17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.52090996 |
18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.41445370 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37218903 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36121362 |
21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.35337860 |
22 | Amoebiasis_Homo sapiens_hsa05146 | 1.24177794 |
23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22084117 |
24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21513267 |
25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20678570 |
26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20017913 |
27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17958561 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13399329 |
29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08841979 |
30 | Insulin resistance_Homo sapiens_hsa04931 | 1.07675867 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.07316170 |
32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04761878 |
33 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03779075 |
34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98422805 |
35 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97419684 |
36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94053820 |
37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92133423 |
38 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.92132588 |
39 | Mineral absorption_Homo sapiens_hsa04978 | 0.91784927 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91592743 |
41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91478248 |
42 | Renin secretion_Homo sapiens_hsa04924 | 0.91405688 |
43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91185878 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 0.91039866 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90706173 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89274597 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84828089 |
48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84762689 |
49 | Prion diseases_Homo sapiens_hsa05020 | 0.84207222 |
50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82912151 |
51 | Pertussis_Homo sapiens_hsa05133 | 0.82854566 |
52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79912194 |
53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78390717 |
54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77194803 |
55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76709150 |
56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76574359 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76120060 |
58 | Tight junction_Homo sapiens_hsa04530 | 0.76095980 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75558784 |
60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74478355 |
61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74259964 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.73391400 |
63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71862344 |
64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71789359 |
65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71003375 |
66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70365306 |
67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70350510 |
68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70295565 |
69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70136714 |
70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69480955 |
71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69314825 |
72 | Adherens junction_Homo sapiens_hsa04520 | 0.68839781 |
73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67725474 |
74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67496556 |
75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66663745 |
76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66396005 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66362131 |
78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66161493 |
79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66095132 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65533211 |
81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65013593 |
82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64509146 |
83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64500768 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63908541 |
85 | Platelet activation_Homo sapiens_hsa04611 | 0.63435302 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62574097 |
87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62083415 |
88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61802794 |
89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61740202 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.60648877 |
91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60562681 |
92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60274037 |
93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60243273 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58632061 |
95 | Phagosome_Homo sapiens_hsa04145 | 0.58428640 |
96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58018197 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.57779008 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56941633 |
99 | Peroxisome_Homo sapiens_hsa04146 | 0.56464270 |
100 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56063953 |
101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54380264 |
102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54159438 |
103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54042990 |
104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53163457 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52976394 |
106 | Bile secretion_Homo sapiens_hsa04976 | 0.51522136 |
107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49808344 |
108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49654596 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49601738 |
110 | Axon guidance_Homo sapiens_hsa04360 | 0.49370059 |
111 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49294131 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48975658 |
113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48738637 |
114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48152248 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47842280 |
116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47474990 |
117 | Hepatitis C_Homo sapiens_hsa05160 | 0.47031179 |
118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46107707 |
119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45834574 |
120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45288122 |
121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45109565 |
122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44771941 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44704950 |
124 | Bladder cancer_Homo sapiens_hsa05219 | 0.44069865 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42303872 |
126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42099476 |
127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42053505 |
128 | Asthma_Homo sapiens_hsa05310 | 0.41829729 |
129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40909981 |
130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39905632 |
131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39861822 |
132 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39769916 |
133 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39046192 |
134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38156679 |
135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37810341 |
136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37784434 |
137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37716244 |
138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36912360 |
139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33371122 |